Bharat Biotech Covaxin
-
{
- All
- News
- Videos
-
No External Pressure To Accelerate Development Of Covaxin: Bharat Biotech
Covid-19 vaccine Covaxin maker Bharat Biotech today said there was no external pressure on the firm to speed up its development.
-
"Covaxin Safe For Kids Aged 2-18": Here's What Bharat Biotech Says On Side-Effects
Data on Covaxin for children has been published online in The Lancet Infectious Diseases journal on June 16
-
"Portrays Incorrect Picture": Government On Reports Of Covaxin Concern
Centre said that reports apparently quoting a communication from the MEA asking vaccine maker Bharat Biotech to address issues to avoid cancellation of WHO's emergency use approval nod for its COVID jab, "potrayed an incorrect picture."
-
"Bharat Biotech Must Address WHO's Covaxin Suspension To Avoid...": Centre
Weeks after WHO suspended the supply of Covaxin through UN procurement agencies, the MEA suggested that vaccine-maker Bharat Biotech addresses the issue immediately to avoid cancellation of the world health body's emergency use approval for the jab.
-
Vaccine Not Sent To UN Bodies, Says Bharat Biotech On WHO Action: Sources
With WHO announcing the suspension of Covaxin supply through UN procurement agencies, Bharat Biotech sources said on Monday the pharma company has not supplied the COVID-19 vaccine to any UN agency and no impact of the suspension would be felt.
-
WHO Suspends UN Supply Of Covaxin; No Impact On Efficacy, Says Bharat Biotech
The World Health Organisation said on Saturday it has suspended supply through United Nations agencies of COVID-19 vaccine Covaxin, produced by India's Bharat Biotech, to allow the manufacturer to upgrade facilities.
-
Covaxin Set To Be Evaluated In US, Says Maker Bharat Biotech
Bharat Biotech on Saturday said its Covaxin will be evaluated as a COVID-19 vaccine candidate in the US.
-
"Received Several Reports": Covaxin-Maker On Unapproved Vaccines To 15-18
Hyderabad-based vaccine manufacturer Bharat Biotech on Friday said that it has received reports of COVID-19 vaccines other than Covaxin are being administered in children of age group 15-18 years in the country.
-
Do Not Give Painkillers To Teens After Covaxin Shot, Says Vaccine-Maker
Bharat Biotech on Wednesday said no painkillers or paracetamol are recommended after being vaccinated with its COVID-19 vaccine Covaxin.
-
Covaxin Meets WHO Criteria For Delta, Shows Lancet Study: Bharat Biotech
Hyderabad-based Bharat Biotech has said that the results compare well with 65.2 per cent efficacy against Delta variant obtained during controlled phase 3 clinical trials of COVAXIN conducted among the general population.
-
Vietnam Approves India's Covid Vaccine Covaxin For Emergency Use
Vietnam has approved India's Covaxin vaccine for emergency use, the ninth to be endorsed in the country, the country's health ministry said on Wednesday.
-
Bharat Biotech's US Partner Files Request With FDA For Covaxin Trials
Ocugen, Bharat Biotech's US partner for COVID-19 vaccine Covaxin, on Wednesday said it has submitted Investigational New Drug Application (IND) to the US Food and Drug Administration to conduct clinical trials.
-
PSU Gets Loan License To Supply Covaxin Drug Substance To Bharat Biotech
Hyderabad-based PSU Indian Immunologicals Limited has received a loan license from drug regulator CDSCO for supplying to Bharat Biotech Covaxin drug substance produced at its repurposed facility, the Department of Biotechnology (DBT) said on Friday.
-
75 Million Covaxin Doses Supplied, Says Bharat Biotech
Bharat Biotech on Thursday informed that the Hyderabad- based company has till now supplied 75 million doses of its Covid-19 vaccine Covaxin and more will be supplied this month.
-
Bharat Biotech Commits 500 Million Doses Of Covaxin To Centre
Bharat Biotech today said it has committed to supply over 500 million doses of its COVID-19 vaccine Covaxin to the Centre under the countrywide immunisation programme.
-
No External Pressure To Accelerate Development Of Covaxin: Bharat Biotech
Covid-19 vaccine Covaxin maker Bharat Biotech today said there was no external pressure on the firm to speed up its development.
-
"Covaxin Safe For Kids Aged 2-18": Here's What Bharat Biotech Says On Side-Effects
Data on Covaxin for children has been published online in The Lancet Infectious Diseases journal on June 16
-
"Portrays Incorrect Picture": Government On Reports Of Covaxin Concern
Centre said that reports apparently quoting a communication from the MEA asking vaccine maker Bharat Biotech to address issues to avoid cancellation of WHO's emergency use approval nod for its COVID jab, "potrayed an incorrect picture."
-
"Bharat Biotech Must Address WHO's Covaxin Suspension To Avoid...": Centre
Weeks after WHO suspended the supply of Covaxin through UN procurement agencies, the MEA suggested that vaccine-maker Bharat Biotech addresses the issue immediately to avoid cancellation of the world health body's emergency use approval for the jab.
-
Vaccine Not Sent To UN Bodies, Says Bharat Biotech On WHO Action: Sources
With WHO announcing the suspension of Covaxin supply through UN procurement agencies, Bharat Biotech sources said on Monday the pharma company has not supplied the COVID-19 vaccine to any UN agency and no impact of the suspension would be felt.
-
WHO Suspends UN Supply Of Covaxin; No Impact On Efficacy, Says Bharat Biotech
The World Health Organisation said on Saturday it has suspended supply through United Nations agencies of COVID-19 vaccine Covaxin, produced by India's Bharat Biotech, to allow the manufacturer to upgrade facilities.
-
Covaxin Set To Be Evaluated In US, Says Maker Bharat Biotech
Bharat Biotech on Saturday said its Covaxin will be evaluated as a COVID-19 vaccine candidate in the US.
-
"Received Several Reports": Covaxin-Maker On Unapproved Vaccines To 15-18
Hyderabad-based vaccine manufacturer Bharat Biotech on Friday said that it has received reports of COVID-19 vaccines other than Covaxin are being administered in children of age group 15-18 years in the country.
-
Do Not Give Painkillers To Teens After Covaxin Shot, Says Vaccine-Maker
Bharat Biotech on Wednesday said no painkillers or paracetamol are recommended after being vaccinated with its COVID-19 vaccine Covaxin.
-
Covaxin Meets WHO Criteria For Delta, Shows Lancet Study: Bharat Biotech
Hyderabad-based Bharat Biotech has said that the results compare well with 65.2 per cent efficacy against Delta variant obtained during controlled phase 3 clinical trials of COVAXIN conducted among the general population.
-
Vietnam Approves India's Covid Vaccine Covaxin For Emergency Use
Vietnam has approved India's Covaxin vaccine for emergency use, the ninth to be endorsed in the country, the country's health ministry said on Wednesday.
-
Bharat Biotech's US Partner Files Request With FDA For Covaxin Trials
Ocugen, Bharat Biotech's US partner for COVID-19 vaccine Covaxin, on Wednesday said it has submitted Investigational New Drug Application (IND) to the US Food and Drug Administration to conduct clinical trials.
-
PSU Gets Loan License To Supply Covaxin Drug Substance To Bharat Biotech
Hyderabad-based PSU Indian Immunologicals Limited has received a loan license from drug regulator CDSCO for supplying to Bharat Biotech Covaxin drug substance produced at its repurposed facility, the Department of Biotechnology (DBT) said on Friday.
-
75 Million Covaxin Doses Supplied, Says Bharat Biotech
Bharat Biotech on Thursday informed that the Hyderabad- based company has till now supplied 75 million doses of its Covid-19 vaccine Covaxin and more will be supplied this month.
-
Bharat Biotech Commits 500 Million Doses Of Covaxin To Centre
Bharat Biotech today said it has committed to supply over 500 million doses of its COVID-19 vaccine Covaxin to the Centre under the countrywide immunisation programme.
